Tag: Dr Anna M Wu
Telix secures advanced biologics technology platform in strategic deal
Telix Pharmaceuticals has announced an asset purchase agreement with antibody engineering firm ImaginAb, Inc, marking the expansion of its capabilities in precision medicine and therapeutic innovation.
Featured Article
Don’t get left behind: Manufacturing’s urgent need for digital transformation
As digital transformation reshapes industries worldwide, manufacturers in Australia and beyond are finding themselves at the forefront of an evolution. This shift presents opportunities for companies looking to improve efficiency, drive innovation, and boost growth.
